Stage III Childhood Lymphoblastic Lymphoma Completed Phase 1 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0030479 (Stage III Childhood Lymphoblastic Lymphoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs